Leukocyte adhesion deficiency II (LAD II), also known as congenital disorder of glycosylation lIc (CDG-llc), is a human disease in which a defective GDP-fucose transporter (SLC35C1) causes developmental defects and an immunodeficiency that is based on the lack of fucosylated selectin ligands. Since the study of in vivo leukocyte trafficking in patients with LAD II is experimentally limited, we analyzed this process in mice deficient for Slc35c1. We found that E-, L-, and Pselectin-dependent leukocyte rolling in cremaster muscle venules was virtually absent. This was accompanied by a strong but not complete decrease in firm leukocyte adhesion. Moreover, neutrophil migration to the inflamed peritoneum was strongly reduced by 89%. Previous reports showed surprisingly normal lymphocyte functions in LAD II, which indicated sufficient lymphocyte trafficking to secondary lymphoid organs. We now found that while lymphocyte homing to lymph nodes was reduced to 1% to 2% in Slc 35c1 -/-mice, trafficking to the spleen was completely normal. In accordance with this, we found a defect in the humoral response to a T cell-dependent antigen in lymph nodes but not in the spleen. Taken together, Slc35c1 -/- mice show strongly defective leukocyte trafficking but normal lymphocyte homing to the spleen, which may explain normal lymphocyte functions in LAD II. © 2008 by The American Society of Hematology.
CITATION STYLE
Yakubenia, S., Frommhold, D., Schölch, D., Hellbusch, C. C., Körner, C., Petri, B., … Wild, M. K. (2008). Leukocyte trafficking in a mouse model for leukocyte adhesion deficiency II congenital disorder of glycosylation lIc. Blood, 112(4), 1472–1481. https://doi.org/10.1182/blood-2008-01-132035
Mendeley helps you to discover research relevant for your work.